R&D

R&D

Pipeline
Pipeline
Clinical Trial Information
Clinical Trial Information

R&D News

View more
  • March 31, 2026 Notice of Dissolution of Joint Venture relationship with respect to BIKEN Co., Ltd. pdf （113KB）
  • March 30, 2026 Tanabe Pharma Announces Positive Data from Phase 3 INSPIRE Study of Dersimelagon in EPP and XLP pdf （799KB）
  • February 2, 2026 Pipeline ― State of New Product Development
  • November 5, 2025 Pipeline ― State of New Product Development
  • October 23, 2025 Receipt of Complete Response Letter from U.S. FDA for investigational ND0612 pdf （199KB）
  1. Tanabe Pharma Corporation
  2. R&D
  3. TOP
  • header-content
  • header-content

  • CLOSE
  • MENU

Site Search

If you agree to the use of cookies, please click the "Agree" button.
If you do not agree, please do not use this site. For details, please refer to the following page.

Privacy Policy

Agree

URL
 

田辺ファーマ株式会社のサイトを離れます。よろしいですか？
（別ウィンドウが開きます）

You are leaving the Tanabe Pharma Corporation’s website.
(A new window will be opened.)

はい / O.K.
いいえ / Cancel
  • footer-content